FDA Laboratory Benchtop Luminometer

FDA's Office of Acquisition and Grant Services intends to solicit a laboratory benchtop luminometer by June 1, 2026, when capability statements are due. This is a sources sought notice (market survey only) with no set-aside; small businesses under NAICS 334516 are the target audience, though large businesses may also respond.

The instrument must read luminescence from luciferase in relation to cell expression and hepatitis C virus studies, replacing an existing non-operational unit at the Center for Biologics and Review, Laboratory of Hepatitis Viruses. Technical requirements include capability to read 96-well plates; an injection system with a minimum of two injectors and variable volume delivery of luciferase reagent; spectral range of 340–630 nanometers; sensitivity readings less than 5 amol ATP per well; detection capability of less than 2 zeptomoles of firefly luciferase; greater than 6 orders of magnitude dynamic range; reasonable laboratory benchtop footprint; PC-compatible software for instrument operation, plate setup, and data analysis; and minimum one-year full manufacturer's warranty with installation and staff training.

Respondents must submit capability statements by email to timothy.walbert@fda.hhs.gov by 2:00 p.m. Central Time on June 1, 2026, referencing SSN 75F40126SSN134302. Submissions must include business information, past performance data from the last three years, technical specifications, descriptive literature, pricing, country of origin, GSA Schedule or government-wide contract availability, and service response capabilities. The government reserves the right to use submitted information for any legally appropriate purpose and will not acknowledge receipt or provide feedback.